Clinical Trial Update: A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine [Phase 2]

View source ↗

Summary

A Phase 2 study to assess long-term brigimadlin treatment in people with solid tumors who previously participated in a brigimadlin trial; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• brigimadlin (brigimadlin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Solid Tumours | Phase 2 | Status: ACTIVE_NOT_RECRUITING